High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller

PURPOSE: To evaluate the risk of recurrence in women diagnosed with T1a and T1b, node-negative, human epidermal growth factor receptor 2 (HER2) –positive breast cancer. METHODS: We reviewed 965 T1a,bN0M0 breast cancers diagnosed at our institution between 1990 and 2002. Dedicated breast pathologists...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gonzalez-Angulo, Ana M., Litton, Jennifer K., Broglio, Kristine R., Meric-Bernstam, Funda, Rakkhit, Ronjay, Cardoso, Fatima, Peintinger, Florentia, Hanrahan, Emer O., Sahin, Aysegul, Guray, Merih, Larsimont, Denis, Feoli, Francesco, Stranzl, Heidi, Buchholz, Thomas A., Valero, Vicente, Theriault, Richard, Piccart-Gebhart, Martine, Ravdin, Peter M., Berry, Donald A., Hortobagyi, Gabriel N.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2009
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2792998/
https://ncbi.nlm.nih.gov/pubmed/19884543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.23.2025
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak